Results 261 to 270 of about 6,393,089 (340)
Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study
Arthritis Care &Research, EarlyView.Objective
Social determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point‐of‐care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and ...S. Sam Lim, Vijay R. Nadipelli, Michelle Bruno, Daphne Lew, Bernard Rubin, Charmayne M. Dunlop‐Thomas, Kelsey Hulcher, Kristi R. Mitchell, Lydia Demetriou, Jeff Berko, Jason Bao, Alfred H. J. Kim +11 morewiley +1 more sourceAssociation of Elevated Serum S100A8/A9 Levels and Cognitive Impairment in Patients With Systemic Lupus Erythematosus
Arthritis Care &Research, EarlyView.Objective
Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE). Despite its prevalence, the immune mechanisms are not well understood. We previously reported elevated serum levels of S100A8/A9 and matrix metalloproteinase 9 (MMP‐9) in patients with SLE and CI.Carolina Muñoz‐Grajales, Michelle L. Barraclough, Juan P. Diaz‐Martinez, Jiandong Su, Kathleen Bingham, Mahta Kakvan, Roberta Pozzi Kretzmann, Maria Carmela Tartaglia, Lesley Ruttan, May Y. Choi, Simone Appenzeller, Sherief Marzouk, Dennisse Bonilla, Patricia Katz, Dorcas Beaton, Robin Green, Dafna D. Gladman, Joan Wither, Zahi Touma +18 morewiley +1 more sourceTowards consensus: The need for standardised definitions in Long (post) COVID care in 34 European countries. [PDF]
Eur J Gen PractGomez-Bravo R, León-Herrera S, Guisado-Clavero M, Gefaell I, Wostmann X, Wössner N, Vinker S, Vassallo La Ferla F, Kırkoç Üçüncü E, Tsigarovski G, Torzsa P, Suija K, Stepanović A, Sentker T, Segernäs A, Seifert B, Sánchez-Castro M, Schneider JG, Repovská A, Petrazzuoli F, Petek D, Perjes A, Parodi López N, Neves AL, Nessler K, Muris J, Mortsiefer A, Moreels S, Meister T, Mäntyselkä P, Murauskienė L, Lingner H, Krztoń-Królewiecka A, Kostic M, Çimen Korkmaz B, Knezevic S, Kazakos S, Karathanos V, Shushman I, Ilkov O, Hoffmann K, Heleno B, Hanževački M, Gjorgjievski D, Frese T, Fournier M, Fitzgerald L, Feldmane S, Dotsenko M, Domeyer PR, Croucher D, Cerny V, Burgers JS, Brutskaya-Stempkovskaya E, Busneag CI, Buono N, Bensemmane S, Bayen S, Bakola M, Assenova R, Adler L, Ares-Blanco S, Astier Peña MP. +62 moreeuropepmc +1 more sourceThe Effect of Topically Administered Compounds on the Galvanic Skin Response**This study was aided by a grant from the G. D. Searle & Co., Chicago, IllinoisFrom the Division of Dermatology, Department of Medicine, University of California, Los Angeles, and the Medical Service, Veterans Administration Center, General Medical and Surgical Hospital, Los Angeles, California, and the Departments of Psychology and Engineering, University of California, Los Angeles, California.
, 1961 Daniel J. Perry, George E. Mount, JEROME S. MALINER +2 moreopenalex +1 more source